MoneyWorks4Me

Cipla informs about quarterly statement of investor complaints

21 Jul 2016 Evaluate

Cipla has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.50
Dr. Reddys Labs. 1235.35
Cipla 1330.00
Lupin 1960.00
Zydus Lifesciences 1123.55
View more..